Inactive Instrument

Calendar AbbVie Euronext Paris

Equities

ABBV

US00287Y1091

Chart calendar AbbVie

631da00e7011e4d24b9f8fa813175d2a.36f5QzR_aSxr7pJXpy3U6T3XOnZP5XM82Q7aWpgk4Ug.icmgEwIWJxg_saoP_n-h21CFcAcC0TxtskyDEv8VjzqAzIwoWhMzSyCX2w~93acef3b3a5e2083b8e4cdd8a843ee8c

Upcoming events on AbbVie

02/06/2024 01:42 am American Society of Clinical Oncology Meeting - Abstract No: 3001
02/06/2024 08:31 pm American Society of Clinical Oncology Meeting - Abstract No: 103
04/06/2024 12:45 am American Society of Clinical Oncology Meeting - Abstract No: 3515
26/07/2024 Q2 2024 Earnings Release (Projected)
25/10/2024 Q3 2024 Earnings Release (Projected)
29/01/2025 Q4 2024 Earnings Release (Projected)
25/04/2025 Q1 2025 Earnings Release (Projected)

Past events on AbbVie

15/05/2024 11:10 pm BofA Securities Health Care Conference
03/05/2024 07:30 pm Annual General Meeting
26/04/2024 06:30 pm Q1 2024 Earnings Call
26/04/2024 05:05 pm Q1 2024 Earnings Release
12/04/2024 Ex-dividend day
27/03/2024 09:00 pm Anti-Aging and Aesthetics Medicine World Congress
27/03/2024 06:30 pm Anti-Aging and Aesthetics Medicine World Congress
27/03/2024 03:45 pm Anti-Aging and Aesthetics Medicine World Congress
27/03/2024 02:15 pm Anti-Aging and Aesthetics Medicine World Congress
14/03/2024 06:30 pm Barclays Global Healthcare Conference
11/03/2024 03:15 am American Academy of Dermatology Meeting
11/03/2024 03:10 am American Academy of Dermatology Meeting
11/03/2024 03:00 am American Academy of Dermatology Meeting
10/03/2024 05:00 am American Academy of Dermatology Meeting
10/03/2024 04:40 am American Academy of Dermatology Meeting
10/03/2024 04:30 am American Academy of Dermatology Meeting
10/03/2024 03:55 am American Academy of Dermatology Meeting
10/03/2024 03:50 am American Academy of Dermatology Meeting
10/03/2024 01:00 am American Academy of Dermatology Meeting - VITILIGO
10/03/2024 12:25 am American Academy of Dermatology Meeting - ALOPECIA AREATA

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
33 266
33 255
0.03%
45 784
45 637
0.32%
56 122
56 238
-0.21%
58 054
58 284
-0.4%
54 318
54 047
0.5%

55 184

EBITDA
Million USD
Released
Forecast
Spread
17 747
16 811
5.57%
22 642
22 766
-0.54%
29 018
29 168
-0.51%
30 961
31 181
-0.7%
25 545
25 858
-1.21%

26 530

EBIT
Million USD
Released
Forecast
Spread
15 730
15 736
-0.04%
21 976
21 832
0.66%
28 215
28 167
0.17%
30 183
30 154
0.1%
24 793
24 926
-0.53%

25 543

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
8 426
12 085
-30.28%
3 398
14 347
-76.32%
12 989
12 579
3.26%
13 477
16 796
-19.76%
6 250
8 933
-30.04%

12 004

Net income
Million USD
Released
Forecast
Spread
7 882
7 753
1.66%
4 616
7 357
-37.26%
11 542
11 140
3.61%
11 836
14 494
-18.34%
4 863
8 288
-41.32%

7 739

EPS
USD
Released
Forecast
Spread
5,28
5,23
0.97%
2,72
4,27
-36.28%
6,45
6,25
3.27%
6,63
8,28
-19.89%
2,72
5,30
-48.69%

5,15

Announcement Date07/02/2003/02/2102/02/2209/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
13 538
13 613
-0.55%
14 583
14 640
-0.39%
14 812
14 944
-0.89%
15 121
15 337
-1.41%
12 225
12 230
-0.04%
13 865
13 520
2.55%
13 927
13 707
1.6%
14 301
14 027
1.96%
12 310
11 936
3.14%

14 009


14 178


14 714


13 237


14 315

EBITDA
Million USD
Released
Forecast
Spread
7 156
7 115
0.58%
7 643
8 083
-5.45%
8 090
8 645
-6.42%
8 072
8 405
-3.96%
5 682
5 686
-0.06%
6 710
6 633
1.16%
6 706
6 681
0.37%
6 447
6 600
-2.32%

5 444


7 100


6 877


7 049







EBIT
Million USD
Released
Forecast
Spread
6 958
6 972
-0.21%
7 440
7 382
0.78%
7 909
7 843
0.85%
7 876
7 778
1.26%
5 503
5 553
-0.9%
6 520
6 398
1.9%
6 510
6 498
0.19%
6 260
6 391
-2.05%
5 195
5 158
0.71%

6 888


6 702


6 793


6 659


6 996

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread












475
5 059
-90.61%
2 610
3 685
-29.17%
1 953
3 960
-50.68%
1 212
3 839
-68.43%
1 755
2 367
-25.86%

3 504


3 346


3 397







Net income
Million USD
Released
Forecast
Spread
4 490
3 473
29.3%
924
4 067
-77.28%
3 949
5 207
-24.16%
2 473
3 781
-34.59%
239
2 405
-90.06%
2 024
2 570
-21.25%
1 778
2 937
-39.46%
822
1 580
-47.98%
1 369
1 220
12.17%

2 264


2 053


2 002


1 115


1 400

EPS
USD
Released
Forecast
Spread
2,51
2,03
23.44%
0,51
2,13
-76.06%
2,21
2,87
-22.91%
1,38
2,71
-49.14%
0,13
1,42
-90.82%
1,14
1,43
-20.46%
1,00
1,72
-41.86%
0,46
2,00
-76.95%
0,77
0,66
16.08%

1,57


1,36


1,38


0,62


0,78

Announcement Date29/04/2229/07/2228/10/2209/02/2327/04/2327/07/2327/10/2302/02/2426/04/24-----